APR 23, 2020 12:06 AM PDT

Making Recombination-Protein Drugs Cost Effective

WRITTEN BY: Nouran Amin

 

In a study published in Nature Communications, scientists used genome-editing techniques to eliminate up to 70 percent of a contaminating protein by mass in recombinant-protein drugs produced by a particular mammalian cell line known as the ‘Chinese Hamster Ovary (CHO) cells`.

"Cells, such as Chinese hamster ovary (CHO) cells, are cultured and used to produce many leading drugs," explained Nathan E. Lewis, Associate Professor of Pediatrics and Bioengineering at the University of California San Diego, and Co-Director of the CHO Systems Biology Center at UC San Diego. "However, in addition to the medications we want, the cells also produce and secrete at least hundreds of their own proteins into the broth. The problem is that some of these proteins can degrade the quality of the drugs or could elicit negative side effects in a patient. That's why there are such strict rules for purification, since we want the safest and most effective medications possible."

The used CRISPR-Cas mediated gene editing approach and observed a significant decrease in purification demands that could potentially lower production costs of higher quality drugs. Using recombinant proteins for drug manufacturing currently accounts for the majority of sales and for treating complex diseases.

Learn more about the use of recombinant proteins in drug manufacturing:

"Host cell proteins can be problematic if they pose a significant metabolic demand, degrade product quality, or are maintained throughout downstream purification," explained Stefan Kol, lead author on the study who performed this research while at DTU. "We hypothesized that with multiple rounds of CRISPR-Cas mediated gene editing, we could decrease host cell protein levels in a stepwise fashion. At this point, we did not expect to make a large impact on HCP secretion considering that there are thousands of individual HCPs that have been previously identified."

Findings were published in the journal Nature Communications.

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 15, 2020
Drug Discovery & Development
Antidepressant May Prevent Worsening of COVID-19 Infections
NOV 15, 2020
Antidepressant May Prevent Worsening of COVID-19 Infections
  Researchers from the Washington University School of Medicine in St. Louis have found that fluvoxamine, a common ...
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
DEC 08, 2020
Drug Discovery & Development
Powerful Antibiotic Targets Mycobacterium
DEC 08, 2020
Powerful Antibiotic Targets Mycobacterium
Mycobacterium abscessus is a pathogenic bacterium know to cause tuberculosis and leprosy. Researchers at Johns Hopkins U ...
DEC 24, 2020
Drug Discovery & Development
New Gene Therapy Targets Deafness
DEC 24, 2020
New Gene Therapy Targets Deafness
New gene therapy study addresses treatment methods for deafness. "In this study we focused on genetic deafness caus ...
DEC 25, 2020
Drug Discovery & Development
Why Some Cancer Cells Are Drug Resistant?
DEC 25, 2020
Why Some Cancer Cells Are Drug Resistant?
Cancer is one of the most prominent diseases in the world. It takes many lives every year and treatment likely faces dru ...
JAN 01, 2021
Microbiology
A New Type of Antibiotics Help the Immune System Fight Pathogens
JAN 01, 2021
A New Type of Antibiotics Help the Immune System Fight Pathogens
Reporting in Nature, scientists have identified a new group of compounds that may help us get out of the antibiotic-resi ...
Loading Comments...